Tugce Kan

Tugce Kan

Auto-generated profile, based on publicly available information

Tugce Kan

Genetic Engineering and Biotechnology Institute, Marmara Research Center (MRC), The Scientific and Technological Research Council of Turkey (TUBITAK), Gebze, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2021 in Phytochemical Analysis
Verified
Journal Article
Open access
PDF file
KDKubra Dogan
Kubra Dogan
EEEBRU EROL
EBRU EROL
MOMuge Didem Orhan
Muge Didem Orhan
ZDZehra Degirmenci
Zehra Degirmenci
TKTugce Kan
Tugce Kan
MGMustafa Guzel
Mustafa Guzel
Introduction: Numerous efforts in natural product drug development are reported for the treatment of Coronavirus. Based on the literature, among these natural plants Artemisia annua L. shows some promise for the treatment of SARS‐CoV‐2.Objective: The main objective of our study was to determine artemisinin content by liquid chromatography electrospray ionisation tandem mass spectrometry (LC‐ESI‐MS/MS), to investigate the in vitro biological activity of artemisinin from the A. annua plants grown in Turkey with various extracted methods, to elaborate in silico activity against SARS‐CoV‐2 using molecular modelling.Methodology: Twenty‐one different extractions were applied. Direct and sequential extractions studies were compared with ultrasonic assisted maceration, Soxhlet, and ultra‐rapid determined artemisinin active molecules by LC‐ESI‐MS/MS methods. The inhibition of spike protein and main protease (3CL) enzyme activity of SARS‐CoV‐2 virus was assessed by time resolved fluorescence energy transfer (TR‐FRET) assay.Results: Artemisinin content in the range 0.062–0.066%. Artemisinin showed significant inhibition of 3CL protease activity but not Spike/ACE‐2 binding. The 50% effective concentration (EC50) of artemisinin against SARS‐CoV‐2 Spike pseudovirus was found greater than 50 μM (EC45) in HEK293T cell line whereas the cell viability was 94% of the control (P < 0.01). The immunosuppressive effects of artemisinin on TNF‐α production on both pseudovirus and lipopolysaccharide (LPS)‐induced THP‐1 cells were found significant in a dose dependent manner.Conclusion: Further studies of these extracts for COVID‐19 treatment will shed light to seek alternative treatment options. Moreover, these natural extracts can be used as an additional treatment option with medicines, as well as prophylactic use can be very beneficial for patients.

1 November 2022 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
YCYUKSEL CETİN
YUKSEL CETİN
SASeyma Aydinlik
Seyma Aydinlik
AGAysen Gungor
Aysen Gungor
TKTugce Kan
Tugce Kan
TATimucin Avsar
Timucin Avsar
SDSerdar Durdagi
Serdar Durdagi
The COVID-19 outbreak caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to have high incidence and mortality rate globally. To meet the increasingly growing demand for new therapeutic drugs and vaccines, researchers are developing different diagnostic techniques focused on screening new drugs in clinical use, developing an antibody targeting a SARS-CoV-2 receptor, or interrupting infection/replication mechanisms of SARS-CoV-2. Although many prestigious research publications are addressing this subject, there is no open access platform where all experimental techniques for COVID-19 research can be seen as a whole. Many researchers have accelerated the development of in silico methods, high-throughput screening techniques, and in vitro assays. This development has played an important role in the emergence of improved, innovative strategies, including different antiviral drug development, new drug discovery protocols, combinations of approved drugs, and setting up new drug classes during the COVID-19 outbreak. Hence, the present review discusses the current literature on these modalities, including virtual in silico methods for instant ligand- and target-driven based techniques, nucleic acid amplification tests, and in vitro models based on sensitive cell cultures, tissue equivalents, organoids, and SARS-CoV-2 neutralization systems (lentiviral pseudotype, viral isolates, etc.). This pack of complementary tests informs researchers about the accurate, most relevant emerging techniques available and in vitro assays allow them to understand their strengths and limitations. This review could be a pioneer reference guide for the development of logical algorithmic approaches for new drugs and vaccine strategies against COVID-19.

19 June 2025 in Process Biochemistry
Verified
Journal Article
Closed access
TMTuğçe Kan Mutlu
Tuğçe Kan Mutlu
BÖBetül Mutlu Özçınar
Betül Mutlu Özçınar
IKİsmet Köksal
İsmet Köksal
RÇRabia Çakır
Rabia Çakır